[1] |
GUO Zhaomeng, ZHANG Hua, ZHANG Peng.
Mechanisms of Orai1 on invasion and epithelial-mesenchymal transformation in nasopharyngeal carcinoma cells
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 420-425.
|
[2] |
GAO Xiaobin, WU Xueliang, WANG Shengjie, SUN Guangyuan, WANG Wenjing, LIANG Feng, ZHAO Yifeng, LIU Zhenxian, ZHANG Yingchun.
Expression of TRIM59 and its correlations with clinicopathological features in colorectal cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 446-450.
|
[3] |
XU Qilu, GAO Hui, RAN Xuehong, WANG Junjun, ZHANG Junying, LIU Liping.
Gene mutation and clinical correlation analyses of myeloid leukemia with abnormal karyotypes
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 296-301,306.
|
[4] |
LI Bo, LI Gairui, ZHAO Wei, PENG Xiaolin, ZHAO Dan, PENG Ji.
Evaluation of sample preservation solution for fecal DNA detection
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 312-316.
|
[5] |
LUO Jiao, ZHANG Kunchi, ZHOU Li.
Analysis of differentially expressed microRNAs between the triple negative breast cancer cell line MDA-MB-231 and its brain metastasis cell line
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 218-224.
|
[6] |
SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo.
Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.
|
[7] |
YANG Xiuyuan, PAN Yuelong.
Expression of CD10 protein in colorectal carcinomas and its clinical significance
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 344-349.
|
[8] |
ZHU Yiqing, ZHANG Tongtong, ZHENG Junwen, HAO Jiajie, CAI Yan, WANG Mingrong, LIANG Jianwei, ZHANG Yu.
Expression status of p-mTOR and its prognostic implication in colorectal cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 161-165.
|
[9] |
ZHANG Jiahong, ZHANG Qingying, ZHANG Yanhong, CHEN Jialian, XIE Fang, LIU Ruiguo, WU Rong, WU Longfei.
Screening and evaluation of gene mutations in a familial hypercholesterolemia family
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 229-232,245.
|
[10] |
CAO Yiyi, LIU Weiying, YOU Xinyue, XI Jing, Chen Ruixue, ZHANG Xinyu, LUAN Yang.
In vitro genotoxicity evaluation of BDE-3, BDE-47 and BDE-209
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(1): 15-20,28.
|
[11] |
MA Xiaobiao, ZHANG Qi, PAN Dingguo.
Association between rs4143815 polymorphism in the B7-H1 gene and risk of colorectal cancer
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(6): 440-443,448.
|
[12] |
ZHENG Kai, WANG Bingyu, XU Xinyun, GENG Hong, HUANG Haiyan, LIU Wei, LONG Dingxin.
Mutagenicity of PM2.5 samples from Shenzhen and Taiyuan
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(6): 483-487.
|
[13] |
YANG Jinru, QIN Lulu, ZHU Yongfei.
Meta analysis on association between JAK2 gene mutation and susceptibility to chronic myeloid leukemia
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 231-237.
|
[14] |
LI Ruowan, ZHOU Changhui, HUANG Pengcheng, CHANG Yan.
Establishment of an in vitro PIG-A gene mutation assay based on TK6 cells for genotoxicity tests
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 242-248.
|
[15] |
ZHANG Feng, ZHAO Long, FAN Jinping, WU Xueling, MENG Shufang.
Induction of tumor in NIH mice by the plasmid containing the V112A and Q61R mutated HRAS
[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(1): 1-8.
|